# The Cigna Group (CI) FY2024 YTD Q3 P&L / Income Statement

- Company: The Cigna Group (CI)
- Period: 2024-01-01 to 2024-09-30
- Filing: Q3 FY2024 10-Q, filed 2024-10-31, accession number 0001739940-24-000033
- Page: https://plicit.ai/financials/ci/fy2024-ytd-q3-income-statement
- Chart image: https://plicit.ai/charts/ci-fy2024-ytd-q3-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2024-01-01 through 2024-09-30. View: Revenue categories. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **TOTAL REVENUES**: 181,472,000,000 US dollars
- **TOTAL BENEFITS AND EXPENSES**: 174,228,000,000 US dollars
- **Income from operations**: 7,244,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 3,984,000,000 US dollars
- **Income before income taxes**: 3,260,000,000 US dollars
- **TOTAL INCOME TAXES**: 1,018,000,000 US dollars
- **Net income**: 2,242,000,000 US dollars
- **Pharmacy revenues**: 135,421,000,000 US dollars
- **Fees and other revenues**: 10,862,000,000 US dollars
- **Premiums**: 34,493,000,000 US dollars
- **Net investment income**: 696,000,000 US dollars
- **Pharmacy and other service costs**: 133,488,000,000 US dollars
- **Medical costs and other benefit expenses**: 28,482,000,000 US dollars
- **Selling, general and administrative expenses**: 10,979,000,000 US dollars
- **Amortization of acquired intangible assets**: 1,279,000,000 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to The Cigna Group: $2.01 B; to noncontrolling interests: $232.00 M.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/ci/fy2024-ytd-q3-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/ci-fy2024-ytd-q3-revenue-by-business-segment-sankey.png

Income statement for 2024-01-01 through 2024-09-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **TOTAL REVENUES**: 181,472,000,000 US dollars
- **TOTAL BENEFITS AND EXPENSES**: 174,228,000,000 US dollars
- **Income from operations**: 7,244,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 3,984,000,000 US dollars
- **Income before income taxes**: 3,260,000,000 US dollars
- **TOTAL INCOME TAXES**: 1,018,000,000 US dollars
- **Net income**: 2,242,000,000 US dollars
- **Evernorth Health Services**: 148,229,000,000 US dollars
- **Cigna Healthcare**: 39,821,000,000 US dollars
- **Other Operations**: 627,000,000 US dollars
- **Pharmacy and other service costs**: 133,488,000,000 US dollars
- **Medical costs and other benefit expenses**: 28,482,000,000 US dollars
- **Selling, general and administrative expenses**: 10,979,000,000 US dollars
- **Amortization of acquired intangible assets**: 1,279,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 188,677,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Corporate and Eliminations**: negative 7,205,000,000 US dollars. Reported reconciliation to consolidated revenue.

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to The Cigna Group: $2.01 B; to noncontrolling interests: $232.00 M.